Discover and read the best of Twitter Threads about #esmo2019

Most recents (4)

Surprise surprise. The group that benefits from 1L pembro is largely driven by MSI-high tumors. This should have been included in the original #ASCO2019 presentation. 😡 #KN062 #ESMO2019
Read 4 tweets
Surprise surprise. Patients with ctDNA detectable post-op do worse. IDEA France stage III. #ESMO2019 Image
Read 3 tweets
FIGHT-202 anti-FGFR2 pemigatinib for FGFR2 fusion cholangiocarcinoma. Very impressive Image
3-arm non-randomized phase 2 Image
Primary endpoint ORR in cohort A FGFR2 fusion cohort Image
Read 9 tweets
Randomized phase 1b (never heard of such a thing?) atezo vs atezo/bev. Looks good. Let’s see the prospective study already accrued and hopefully reading out soon. #ESMO2019 Image
IMBRAVE150 sorafenib vs atezo/bev
Phase 3 first line study
Waterfall plot impressive. Let’s see if it holds up in phase 3 Image
Read 3 tweets

Related hashtags

Did Thread Reader help you today?

Support us! We are indie developers!

This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3.00/month or $30.00/year) and get exclusive features!

Become Premium

Too expensive? Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal Become our Patreon

Thank you for your support!